TSH-secreting pituitary carcinoma with intrathecal drop metastases

Clinical Endocrinology

Volumn 76, Issue 4, 2012, Pages 604-606

  Lee, Will ^a   Cheung, Ada S ^b   Freilich, Ron ^c  

^a ALFRED HOSPITAL   (Australia)

^b AUSTIN HEALTH   (Australia)

^c CABRINI HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIMAZOLE; CISPLATIN; ETOPOSIDE; TEMOZOLOMIDE; THYROTROPIN; THYROXINE;

ADENOMA; AGED; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; ELECTROMYOGRAPHY; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS ADENOMA; LETTER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PITUITARY MACROADENOMA; PRIORITY JOURNAL; RADICULOPATHY; THYROID FUNCTION TEST;

AGED; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PITUITARY NEOPLASMS; THYROTROPIN;

EID: 84863249093     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04288.x     Document Type: Letter

References (5)

1. Kaltsas, G.A., Nomikos, P., Kontogeorgos, G. et al. (2005) Clinical review: diagnosis and management of pituitary carcinomas. The Journal of Clinical Endocrinology and Metabolism, 90, 3089-3099. (Pubitemid 40686369)
2. Brown, R.L., Muzzafar, T., Wollman, R. et al. (2006) A pituitary carcinoma secreting TSH and prolactin: a non-secreting adenoma gone awry. European Journal of Endocrinology, 154, 639-643. (Pubitemid 43810848)
3. Mixson, A.J., Friedman, T.C., Katz, D.A. et al. (1993) Thyrotropin-secreting pituitary carcinoma. The Journal of Clinical Endocrinology and Metabolism, 76, 529-533. (Pubitemid 23073087)
4. Azzawi, H., Yacqub-Usman, K., Richardson, A. et al. (2011) Reversal of endogenous dopamine receptor silencing in pituitary cells augments receptor-mediated apoptosis. Endocrinology, 152, 364-373.
5. Raverot, G., Sturm, N., de Fraipont, F. et al. (2010) Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience. The Journal of Clinical Endocrinology and Metabolism, 95, 4592-4599.